LARIMAR THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
LARIMAR THERAPEUTICS, INC. (LRMR) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.83 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-04
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.83M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.27M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.48M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.48M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $1.83M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.27M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.48M 10-K · filed 2026-03-19 |
| 2025-09-30 | $1.48M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.48M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.47M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $1.54M 10-K · filed 2025-03-24 |
| 2024-09-30 | $1.54M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $1.54M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.40M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.38M 10-K · filed 2024-03-14 |
| 2023-09-30 | $1.25M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.06M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.06M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.15M 10-K · filed 2023-03-14 |
| 2022-09-30 | $1.15M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.15M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.15M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.20M 10-K · filed 2022-03-25 |
| 2021-09-30 | $1.20M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.20M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.20M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.18M 10-K · filed 2021-03-04 |
| 2020-09-30 | $1.18M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.18M 10-Q · filed 2020-08-14 |
| 2019-12-31 | $1.09M 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |